NGI-1, also known s ML414, is a a cell-permeable inhibitor of oligosaccharyltransferase (OST). In non-small-cell lung cancer cell lines that are dependent on EGFR, OST inhibition causes cell-cycle arrest accompanied by induction of p21, autofluorescence, and cell morphology changes.
Synonyms:
5-[(Dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide;
NGI-1;
Benzamide, 5-[(dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)-;
Antiviral Inhibitors Related Products:
Vadimezan; Geldanamycin; UNC0638; U0126-EtOH; Tenofovir; Baloxavir; Tubacin; Emricasan; Remdesivir; Baloxavir marboxil; Famciclovir; Epigoitrin; Ribavirin